Eyam Welcomes Wolfgang Koester to Board of Directors

Eyam Vaccines and Immunotherapeutics announced the appointment of Wolfgang Koester, recognized as one of the "100 Most Influential People in Finance," to its Board of Directors. This move highlights Eyam's commitment to enhancing its collaborations on its AI-driven bioinformatics platform and innovative self-amplifying vaccine and immunotherapeutic platforms.

Ryan M. Thomas, CEO of Eyam, expressed confidence in Koester's abilities to foster global business development and enhance the company’s governance. Koester's over three decades of experience spans financial markets and entrepreneurship, with notable roles including CEO of IndependentBOD, Chief Evangelist at Kyriba, and co-founder of FiREapps Inc and GFTA Inc.

Koester shared his excitement about joining Eyam, emphasizing the BioTech industry's shift towards Generative AI, increased collaboration, and innovative de-risking strategies. He praised Eyam for its visionary approach and solution-based platform design.

With Koester’s appointment, Eyam aims to further its research and development, expand business efforts, and continue making impactful strides in combatting disease through innovative vaccine and immunotherapeutic technologies.